Who We Are

Hahn-Jun Lee, M.Sc., Ph.D CSO

Dr. Lee is a serial entrepreneur who founded Epygenix Therapeutics, Inc., Polaryx Therapeutics, Inc, and Focus Therapeutics, LLC, and co-founded Curyx Partners, L.L.C., Curyx Bio, Inc, and Medeoryx Therapeutics, Ltd. He has long been involved in R&D, licensing, deal making, business development, and consulted top healthcare venture capital firms and global pharma and biotechs, such as Doman Associates, Shire Human Genetic Therapy, P&G Pharma, Melior Discovery, CDI, and etc. He also consulted Korean biotechs, venture capital firm, and research institutes.

Dr. Lee was an Assistant Professor of Biotechnology at the Department of Orthopedic Surgery, College of Physicians and Surgeons, Columbia University in the city of New York. He also worked as a Staff Scientist at the RIKEN Brain Science Institute in Japan.

He obtained his B.S. in life science at Sogang University, Seoul, Korea. He completed his M.Sc. and Ph.D. in applied biotechnology at the Department of Applied Biotechnology in the University of Tokyo, Japan.

Management team has extensive experiences in biotech business, R&D, deal making, and financing.